Gene transfer techniques for cardiac arrhythmias

References

• MacMahon S, Collins R, Peto R, Koster R, Yusuf S. Effect of prophylactic lidocaine in suspected acute myocardial infarc-tion: An overview of results from the randomized, controlled trials. JAMA 1988;260:1910–6.
   Google Scholar
• Echt D, Liebson P, Mitchell L, Peters R, Obias-Manno D, Barker A, et al, Cardiac Arrhythmia Suppression Trial Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991; 324: 781–8.
   Google Scholar
• Waldo A, Camm A, deRuyter H, Friedman P, MacNeil D, Pauls J, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocar-dial infarction. Lancet 1996;348:7–12.
   Google Scholar
• Calkins H, Yong P, Miller J, Olshansky B, Carlson M, Saul J, et al. Catheter ablation of accessory pathways, atrioventri-cular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 1999;99:262–70.
   Google Scholar
• Jais P, Haissaguerre M, Shah D, Chouairi S, Gencel L, Hocini M, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572–6.
   Google Scholar
• Parsonnet V, Bernstein A, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 1989;13:917–21.
   Google Scholar
• Knight B, Weiss R, Bahu M, Souza J, Zivin A, Goyal R, et al. Cost comparison of radiofrequency modification and ablation of the atrioventricular junction in patients with chronic atrial fibrillation. Circulation 1997;96:1532–6.
   Google Scholar
• Lin H, Parmacek M, Morle G, Bolling S, Leiden J. Expression of recombinant genes in the myocardium in vivo after direct injection of DNA. Circulation 1990;82:2217–21.
   Google Scholar
• Nabel E, Plautz G, Nabel G. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249:1285–8.
   Google Scholar
• Prazeres D, Ferreira G, Monteiro G, Cooney C, Cabral J. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol 1999;17:169–74.
   Google Scholar
• Barry M, Pinto-Gonzalez D, Orson F, McKenzie G, Petry G, Barry M. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther 1999;10:2461–80.
   Google Scholar
• Ghosh-Choudhury G, Haj-Ahmad Y, Graham F. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J 1987;6: 1733–9.
   Google Scholar
• Chen HH, Mack LM, Kelly R, Ontell M, Kochanek S, Clemens PR. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci USA 1997;94:1645–50.
   Google Scholar
• Louis N, Fender P, Barge A, Kitts P, Chroboczek J. Cell-Binding Domain of Adenovirus Serotype 2 Fiber. J Virol 1994; 68:4104–6.
   Google Scholar
• Bergelson J, Cunningham JA, Droguett G, Kurtjones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320–3.
   Google Scholar
• Cohen C, Shieh J, Pickles R, Okagawa T, Hseih J, Bergelson J. The coxsackievirus and adenovirus receptor is a transmem-brane component of the tight junction. Proc Natl Acad Sci USA 2001;98:15191–6.
   Google Scholar
• Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins °evils and avils promote adenovirus internalization but not virus attachment. Cell 1993;73:309–19.
   Google Scholar
• Shenk T. Adenoviridae: The Viruses and Their Replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott-Raven; 1996:2111–48.
   Google Scholar
• Donahue J, Heldman A, Fraser H, McDonald A, Miller J, Rade J, et al. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med 2000;6:1395–8.
   Google Scholar
• Hajjar R, Schmidt U, Matsui T, Guerrero L, Lee K, Gwathmey J, et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 1998; 95:5251–6.
   Google Scholar
• Cross H, Steenbergen C, Lefkowitz R, Koch W, Murphy E. Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury. Circ Res 1999;85: 1077–84.
   Google Scholar
• Rade J, Schulick A, Virmani R, Dichek D. Local adenoviral-mediated expression of recombinant hirudin reduces neointi-ma formation after arterial injury. Nat Med 1996;2:293–8.
   Google Scholar
• Deguchi J, Namba T, Hamada H, Nakaoka T, Abe J, Sato O, et al. Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther 1999;6:956–65.
   Google Scholar
• Varenne O, Pislaru S, Gillijms H, Van Pelt N, Gerard R, Zoldhelyi P, et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 1998;98:919–26.
   Google Scholar
• Chang M, Barr E, Lu M, Barton K, Yehodi S, Leiden J. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995;96:2260–8.
   Google Scholar
• Scheinman M, Ascher E, Levi G, Hingorani A, Shirazian D, Seth P. p53 gene transfer to the injured rat carotid artery decreases neointimal formation. J Vasc Surg 1999;29:360–9.
   Google Scholar
• Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999;401:517–8.
   Google Scholar
• Hoggan M, Blacklow N, Rowe W. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci USA 1966;55:1467–74.
   Google Scholar
• Srivastava A, Lusby E, Berns K. AAV-2 genome sequence. J Virol 1983;45: 564.
   Google Scholar
• Carter B, Laughlin C, Marcus-Secura C. Parvovirus Tran-scription. In: Berns K, editor. The Parvoviruses. New York: Plenum Press; 1984:153–208.
   Google Scholar
• Summerford C, Samulski R. Membrane-associated heparna sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998;72:1438–45.
   Google Scholar
• Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Natu Med 1999;5:71–7.
   Google Scholar
• Summerford C, Bartlett J, Samulski RJ. 0(05 integrin: a co-receptor for adeno-associated virus type 2 infection. Natu Med 1999;5: 78–82.
   Google Scholar
• Weitzman M, Kyostio S, Kotin R, Owens R. Adeno-associated virus (AAV) rep proteins mediate complex forma-tion between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 1994;91:5808–12.
   Google Scholar
• Ferrari F, Samulski T, Shenk T, Samulski R. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996;70: 3227–34.
   Google Scholar
• Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date M, Gu Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002;8:864–71.
   Google Scholar
• Guzman RJ, Lemarchand P, Crystal R, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993;73:1202–7.
   Google Scholar
• Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 1993;90:11498–502.
   Google Scholar
• Donahue J, Kikkawa K, Johns D, Marban E, Lawrence J. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci USA 1997;94:4664–8.
   Google Scholar
• Donahue J, Kikkawa K, Thomas AD, Marban E, Lawrence J. Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin. Gene Therapy 1998;5:630–4.
   Google Scholar
• Breil I, Koch T, Belz M, Vanackern K. Effects of bradykinin, histamine and serotonin on pulmonary vascular resistance and permeability. Acta Physiol Scand 1997;159:189–98.
   Google Scholar
• Nagata K, Marban E, Lawrence J, Donahue J. Phospho-diesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium. J Mol Cell Cardiol 2001;33:575–80.
   Google Scholar
• Miake J, Marban E, Nuss H. Biological pacemaker created by gene transfer. Nature 2002;419:132–3.
   Google Scholar
• Qu J, Plotnikov A, Danilo PJ, Shlapakova I, Cohen I, Robinson R, et al. Expression and function of a biological pacemaker in canine heart. Circulation 2003;107:1106–9.
   Google Scholar